- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/555 - Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
Patent holdings for IPC class A61K 31/555
Total number of patents in this class: 1794
10-year publication summary
|
141
|
182
|
151
|
181
|
119
|
147
|
136
|
119
|
119
|
70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Galera Labs, LLC | 53 |
29 |
| Mayo Foundation for Medical Education and Research | 3202 |
21 |
| Centre National de La Recherche Scientifique | 10418 |
19 |
| The Regents of the University of California | 19887 |
18 |
| Genentech, Inc. | 3972 |
16 |
| Biomimetix JV, LLC | 20 |
16 |
| Board of Regents, The University of Texas System | 5782 |
15 |
| Duke University | 3065 |
15 |
| Bristol-myers Squibb Company | 4875 |
13 |
| Isofol Medical AB | 40 |
13 |
| The Procter & Gamble Company | 22028 |
12 |
| Massachusetts Institute of Technology | 10041 |
11 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
11 |
| Pharmacosmos A/S | 66 |
11 |
| Pharmacosmos Holding A/S | 200 |
11 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2809 |
10 |
| Viking Scientific, Inc. | 13 |
10 |
| Aardvark Therapeutics Inc. | 48 |
10 |
| AstraZeneca AB | 2923 |
9 |
| Amgen Inc. | 4073 |
9 |
| Other owners | 1515 |